Decrease in circulating autotaxin by oral administration of prednisolone

Hayakazu Sumida, Kazuhiro Nakamura, Keisuke Yanagida, Ryunosuke Ohkawa, Yoshihide Asano, Takafumi Kadono, Kunihiko Tamaki, Koji Igarashi, Junken Aoki, Shinichi Sato, Satoshi Ishii, Takao Shimizu, Yutaka Yatomi

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)


Background: Autotaxin (ATX), secreted mainly from adipose tissue, functions as a lysophospholipase D (lysoPLD) to hydrolyze lysophosphatidylcholine (LPC) into lysophosphatidic acid (LPA). ATX-LPA signaling is implicated in a wide range of physiological and pathophysiological processes including immune response. Methods: The present study measured serum ATX antigen levels in patients with various autoimmune diseases using a recently developed automated enzyme immunoassay. In addition, serum lysoPLD activity was assessed by measuring choline liberation from the substrate LPC. Moreover, the effect of prednisolone (PSL) on mRNA expression of ATX was evaluated using cultured adipose tissue from mice. Results: Decreased serum ATX antigen levels were observed after the initiation of treatment with PSL. The decreased levels recovered during tapering of PSL dose in a dose-dependent manner without exacerbation of disease activity. Moreover, decreased ATX mRNA expression in PSL-treated cultured murine adipose tissue suggested that the effect of PSL on serum ATX may have resulted from changes in adipose tissue ATX expression. Conclusions: Our results suggest that measurement of serum ATX antigen level may be clinically useful for the assessment of steroid treatment effect and drug compliance with steroids. Furthermore, our findings provide many novel insights into the biosynthesis, physiological functions, pathological roles, and clinical significance of circulating ATX.

Original languageEnglish
Pages (from-to)74-80
Number of pages7
JournalClinica Chimica Acta
Publication statusPublished - 2013 Jan 16


  • Autotaxin (ATX)
  • Lysophosphatidic acid (LPA)
  • Lysophospholipase D (LysoPLD)
  • Lysophospholipid
  • Prednisolone (PSL)


Dive into the research topics of 'Decrease in circulating autotaxin by oral administration of prednisolone'. Together they form a unique fingerprint.

Cite this